Resistant Hypertension - Products under Development by Companies


Posted January 10, 2017 by smith121

ReportsWeb.com has announced the addition of the “Resistant Hypertension - Pipeline Review, H2 2016”

 
Pharmaceutical and Healthcare latest pipeline guide Resistant Hypertension - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Resistant Hypertension (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Resistant Hypertension (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Resistant Hypertension and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 1, 2, 1 and 1 respectively.
Resistant Hypertension (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
For more information about this report at http://www.reportsweb.com/resistant-hypertension-pipeline-review-h2-2016
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Global Markets Direct
Website Resistant Hypertension - Products under Development by Companies
Phone +1-646-491-9876
Country India
Categories Health
Tags Health , healthcare , health market , Health Industry
Last Updated January 10, 2017